Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Some front page love from Stockhouse
View:
Post by mdjbrown on Oct 26, 2023 12:35am

Some front page love from Stockhouse

https://stockhouse.com/news/the-market-herald-news/2023/10/25/medipharm-resolves-agreement-dispute-with-tilray,-receives-$7-27m


Interesting but cryptic comment:

"MediPharm’s leadership team said in a news release it believes this gives the company a strong position to continue to invest in the pharmaceutical and clinical pipelines and to thoughtfully consider approaches to the many available consolidation opportunities in the industry."
Comment by Solid1 on Oct 26, 2023 6:06am
The many consolidation opportunities... it seems that some companies are already lining up to do this 
Comment by subaru1i on Oct 26, 2023 9:04am
md...when the volume surges making your eyes pop open....Pfizer will be buying up stock in LABS on the open market....with no halt trade issued by LABS on such heavy volume, that will be your confirmation...enjoy the excitement and head rush.  Keeper π   
Medipharm Labs Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities